| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 03/22/2001 | CA2382725A1 Transgenically produced fusion proteins |
| 03/22/2001 | CA2382683A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-¬4-(2-amin-1-yl-ethoxy)-benzyl|-1h-indol-5-ols |
| 03/22/2001 | CA2382633A1 Phospholipid prodrugs of anti-proliferative drugs |
| 03/22/2001 | CA2382544A1 Methods of peptide preparation |
| 03/22/2001 | CA2381078A1 Method of potentiating chemotherapy and treating solid tumors |
| 03/22/2001 | CA2381066A1 Polymorphisms in the human hpxr gene and their use in diagnostic and therapeutic applications |
| 03/22/2001 | CA2379541A1 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/21/2001 | EP1085011A1 Novel polyamine analogues as therapeutic and diagnostic agents |
| 03/21/2001 | EP1084569A2 Pharmaceutical combinations for compensating for a testosterone deficiency in men while simultaneously protecting the prostate |
| 03/21/2001 | EP1084255A1 Tankyrase, a trf1 binding protein |
| 03/21/2001 | EP1084246A2 Biological material for preparing pharmaceutical compositions for treating mammals |
| 03/21/2001 | EP1084245A1 Human receptor tyrosine kinase |
| 03/21/2001 | EP1084145A2 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use thereof for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/21/2001 | EP1084120A1 Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agents |
| 03/21/2001 | EP1084114A1 Isothiazole derivatives useful as anticancer agents |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083937A1 Radioioinated phenols for brachytherapy |
| 03/21/2001 | EP1083928A1 Method of inhibiting angiogenesis and tumor growth and preventing tumor growth and metastases |
| 03/21/2001 | EP1083927A1 HUMAN MINOR VAULT PROTEIN p193 |
| 03/21/2001 | EP1083914A1 Treatment of arthritis and other similar conditions |
| 03/21/2001 | EP1083909A1 hCEPR RECEPTOR |
| 03/21/2001 | EP1083905A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (dhea) or analogues |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP1083903A1 Bridged indenopyrrolocarbazoles |
| 03/21/2001 | EP1083898A1 Novel use of hiv protease inhibiting compounds |
| 03/21/2001 | EP1083890A1 N-acetyl 3-chloroprocainamide, acid addition salts thereof, and methods of use |
| 03/21/2001 | CN1288469A Monoclonal antibody anti alpha; V-integrin and it use to inhibit & alpha; V & beta; 6-integrain attachment to fibronectine |
| 03/21/2001 | CN1288463A Alternate method for acylating 10-deactetylbaccatin III selectively at the C-10 position |
| 03/21/2001 | CN1288382A Sea cucumber carotenoid lipid fraction products and method of use |
| 03/21/2001 | CN1288378A Celecoxib compositions |
| 03/21/2001 | CN1288012A Antisense nucleic acid pointing at urokinase type plasminogen activating agent gene for inhibiting carcer |
| 03/21/2001 | CN1288010A Water soluble cephalotaxin phosphorus poly aminoacid ester or its salt, pharmaceutical compositions contg. same, and pharmaceutical use thereof |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1287860A Application of thyroxine for treating tumor |
| 03/21/2001 | CN1287839A Compound injection for treating cancer and prepn. method therefor |
| 03/21/2001 | CN1063438C Alkenyl-benzoyl guanidine derivant, prepn. method and use thereof |
| 03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |
| 03/20/2001 | US6204370 MN gene and protein |
| 03/20/2001 | US6204366 Specific binding agents |
| 03/20/2001 | US6204364 Cell growth factor; for the treatment of cell proliferation and differentiation defects |
| 03/20/2001 | US6204359 Form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 03/20/2001 | US6204290 Treating a hypercholesteremic, thrombotic, oxidative, inflammatory, or immunoregulatory disease |
| 03/20/2001 | US6204286 8-(p-(pyrrolidinylalkoxy)phenyl)tetrahydronaphthols |
| 03/20/2001 | US6204280 Oxazolidinone derivative, anticoagulant |
| 03/20/2001 | US6204267 Methods of modulating serine/thereonine protein kinase function with quinazoline-based compounds |
| 03/20/2001 | US6204266 Pharmaceutical, cosmetic and/or food composition having anti-oxidant properties |
| 03/20/2001 | US6204261 Inhibitors of interleukin-1β Converting enzyme inhibitors |
| 03/20/2001 | US6204257 Drug delivery |
| 03/20/2001 | US6204241 Polypeptides found in vertebrate species, which polypeptides are mitogenic growth factors for glial cells, including schwann cells. |
| 03/20/2001 | US6204055 Antisense inhibition of Fas mediated signaling |
| 03/20/2001 | US6204052 Nucleotide sequence associated with preferential gene expression; for use in cancer gene therapy and treatment of autoimmune diseases or infections |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204022 Low-toxicity human interferon-alpha analogs |
| 03/20/2001 | US6204001 Methods for determining compounds capable of inhibiting the activities of the Ha-Ras oncongene |
| 03/20/2001 | US6204000 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 03/20/2001 | US6203800 Screening for antibacterial agents; genetic engineering |
| 03/20/2001 | US6203795 Polypeptide; antibody h23 recognizes tumor antigen expressed on breast cancer cells |
| 03/20/2001 | US6203787 Treating tumors using implants comprising combinations of allogeneic cells |
| 03/20/2001 | CA2180571C Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
| 03/20/2001 | CA2102429C Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 03/20/2001 | CA1341207C Analogues of insulin-like growth factor-1 |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018207A1 Human 7tm proteins receptors and polynucleotides encoding the same |
| 03/15/2001 | WO2001018206A1 Human g-protein coupled 7 transmembrane receptor and polynucleotides encoding the same |
| 03/15/2001 | WO2001018204A1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018171A2 Novel class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof |
| 03/15/2001 | WO2001018169A2 Agents and compositions and methods for diagnostic and/or treating or preventing plaque forming diseases |
| 03/15/2001 | WO2001018051A2 Mammalian interleukin-12 p40 and interleukin b30, combinations thereof, antibodies, uses in pharmaceutical compositions |
| 03/15/2001 | WO2001018042A2 Apoptosis proteins |
| 03/15/2001 | WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation |
| 03/15/2001 | WO2001018035A2 Muc-1 derived peptides |
| 03/15/2001 | WO2001018029A1 Novel betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis |
| 03/15/2001 | WO2001018028A1 Novel c13-substituted estra-1,3,5(10)-triene-3-yl-sulfamates, a method for producing the same and pharmaceutical compositions containing these compounds for inhibiting oestrone sulfatase |
| 03/15/2001 | WO2001018026A1 Steroids, their preparation, pharmaceutical compositions thereof and uses of the compounds |
| 03/15/2001 | WO2001018025A2 17alpha propynyl 11-aryl steroids |
| 03/15/2001 | WO2001018024A1 Antisense modulation of x-linked inhibitor of apoptosis expression |
| 03/15/2001 | WO2001018023A1 Antisense modulation of pi3 kinase p110 beta expression |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018015A1 Oligonucleotide n3'→p5' thiophosphoramidates: their synthesis and use |
| 03/15/2001 | WO2001018014A1 29 human cancer associated proteins |
| 03/15/2001 | WO2001018013A1 Prodrugs for liver specific drug delivery |
| 03/15/2001 | WO2001018006A1 Inhibitors of prenyl-protein transferase |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017988A1 Novel chalcones |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017985A1 Novel derivatives of flavones, xanthones and coumarins |
| 03/15/2001 | WO2001017984A1 Chalcone coumarins |
| 03/15/2001 | WO2001017976A1 Bis-sulfonamides |
| 03/15/2001 | WO2001017959A2 Vitronectin receptor antagonists |
| 03/15/2001 | WO2001017614A2 Methods and compositions containing succinimide or maleimide derivatives of antineoplastic agents |
| 03/15/2001 | WO2001017568A2 Bioconjugation in vivo to pulmonary or blood components |
| 03/15/2001 | WO2001017563A2 Integrin-mediated drug targeting |
| 03/15/2001 | WO2001017559A1 Semaphorin modulation of immune cell migration |
| 03/15/2001 | WO2001017551A2 Combined vaccine compositions |
| 03/15/2001 | WO2001017543A2 Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer |
| 03/15/2001 | WO2001017540A1 A pharmaceutical ayurvedic preparation |